Kenji Miki

Kenji Miki

Auto-generated profile, based on publicly available information

Kenji Miki

University of Pittsburgh School of Medicine Department of Neurosurgery 200 Lothrop St, Pittsburgh, Pennsylvania, 15213

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in World Neurosurgery
Verified
Journal Article
Closed access
KMKenji Miki
Kenji Miki
KYKoji Yoshimoto
Koji Yoshimoto
ANAtaru Nishimura
Ataru Nishimura
SSSatoshi O. Suzuki
Satoshi O. Suzuki
AHAkio Hiwatashi
Akio Hiwatashi
KIKoji Iihara
Koji Iihara

25 October 2025 in Neuro-Oncology
Verified
Journal Article
Open access
MSMilan R Savani
Milan R Savani
MSMohamad El Shami
Mohamad El Shami
KMKenji Miki
Kenji Miki
LGLauren C Gattie
Lauren C Gattie
BSBailey C Smith
Bailey C Smith
SMSamuel McBrayer
Samuel McBrayer
Background: In vivo stable isotope tracing is useful for natively surveying glioma metabolism but can be difficult to implement. Stable isotope tracing is tractable using in vitro glioma models, but most models lack nutrient conditions and cell populations relevant to human gliomas. This limits our ability to study glioma metabolism in the presence of an intact tumor microenvironment (TME) and immune-metabolic crosstalk. Methods: We optimized an in vitro stable isotope tracing approach for human glioma explants and glioma stem-like cell (GSC) lines that integrates human plasma-like medium (HPLM). We performed 15N2-glutamine tracing in GSC monocultures and human IDH-wildtype glioblastoma explants and developed an analytical framework to evaluate microenvironment-dependent metabolic features that distinguish them. We also conducted spatial transcriptomics to assess transcriptional correlates to metabolic activities. Results: Human plasma-like medium culture preserved glioma explant viability and stemness while unmasking metabolic and immune programs suppressed by conventional culture conditions. Stable isotope tracing in HPLM revealed TME-dependent and TME-independent features of tumor metabolism. Tissue explants recapitulated tumor cell-intrinsic metabolic activities, such as synthesis of immunomodulatory purines. Unlike GSC monocultures, tissue explants captured tumor cell-extrinsic activities associated with stromal cell metabolism, as exemplified by astrocytic guanosine diphosphate mannose production in heterocellular explants. Finally, glioma explants displayed tumor subtype-specific metabolic reprogramming, including robust pyrimidine degradation in mesenchymal cells. Conclusions: We present a tractable approach to assess glioma metabolism in vitro under physiologic nutrient levels and in the presence of an intact TME. This platform opens new avenues to interrogate glioma metabolism and its interplay with the immune microenvironment.

1 January 2019 in NMC Case Report Journal
Verified
Journal Article
Open access
PDF file
KMKenji Miki
Kenji Miki
YNYoshihiro Natori
Yoshihiro Natori
MMMegumu Mori
Megumu Mori
YKYasutoshi Kai
Yasutoshi Kai
TYTetsuhisa Yamada
Tetsuhisa Yamada
NNNaoki Noguchi
Naoki Noguchi
Trigeminal neuralgia is caused by compression of the trigeminal nerve by arteries or veins in the posterior fossa. A persistent primitive trigeminal artery variant (PPTAv) is an anomalous artery that may cause trigeminal neuralgia. A 65-year-old man presented with left facial pain. Brain magnetic resonance imaging revealed a PPTAv. Constructive interference in steady state showed that both the PPTAv and the superior cerebellar artery (SCA) compressed the trigeminal nerve. Thus, we performed microvascular decompression and the patient’s symptoms improved. PPTAv is a rare anomaly in the posterior fossa that can cause trigeminal neuralgia. Dual compression of the trigeminal nerve by the SCA and PPTAv demonstrates that trigeminal neuralgia may originate from multiple sources. It is therefore important to check preoperative images to adequately treat trigeminal neuralgia.

1 April 2019 in World Neurosurgery
Verified
Journal Article
Closed access
KMKenji Miki
Kenji Miki
YKYasutoshi Kai
Yasutoshi Kai
YHYuka Hiraki
Yuka Hiraki
HKHironori Kamano
Hironori Kamano
KOKazunari Oka
Kazunari Oka
YNYoshihiro Natori
Yoshihiro Natori

1 July 2019 in World Neurosurgery
Verified
Journal Article
Closed access
KMKenji Miki
Kenji Miki
YNYoshihiro Natori
Yoshihiro Natori
YKYasutoshi Kai
Yasutoshi Kai
MMMegumu Mori
Megumu Mori
TYTetsuhisa Yamada
Tetsuhisa Yamada
NNNaoki Noguchi
Naoki Noguchi

1 March 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
KMKenji Miki
Kenji Miki
YNYoshihiro Natori
Yoshihiro Natori
YKYasutoshi Kai
Yasutoshi Kai
TYTetsuhisa Yamada
Tetsuhisa Yamada
MMMegumu Mori
Megumu Mori
HKHidenobu Koga
Hidenobu Koga